Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Eurasian Journal of Medicine and Oncology is Scopus-indexed (Q3, CiteScore 1.1), WoS ESCI. Published by AccScience Publishing.
Checked against the index lists dated .
ISSN 2587-196XVerify ISSN ↗2587-2400Verify ISSN ↗
Publisher: AccScience Publishing
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 130 / 179 | 27th | Q3 |
| Oncology | 335 / 428 | 21st | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 1.1.
Eurasian Journal of Medicine and Oncology is Q3 in Internal Medicine (rank 130 of 179) and Q4 in Oncology (rank 335 of 428), by CiteScore 2025.
Eurasian Journal of Medicine and Oncology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.1, which places it in quartile Q3 at the 27th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.238, quartile Q3, with an H-index of 15.
Eurasian Journal of Medicine and Oncology is published by AccScience Publishing. Its print ISSN is 2587-196X and its online ISSN is 2587-2400.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Eurasian Journal of Medicine and Oncology has an h-index of 17 and a 2-year mean of 0.67 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q3. On 2-year citations it ranks #120 of 172 Scopus journals in Internal Medicine.
Eurasian Journal of Medicine and Oncology published 160 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 85 research articles (2026), authors are most often from China (41.2%), Italy (8.5%) and Saudi Arabia (6.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.